The challenges of coding cancer of unknown primary A survey of registration and reporting practices in the UK, Ireland and Australia Claudia Oehler 1,

Slides:



Advertisements
Similar presentations
Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Advertisements

Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
Investigating variations in the use of GIS within the NHS Gary Higgs (University of Glamorgan) Myles Gould & Darren Smith (University of Leeds) ESRC funded.
Integrated Care Pathways (ICPs) Ali El-Ghorr Rosie Cameron
Study on the outcomes of teaching and learning about ‘race’ and racism Kish Bhatti-Sinclair (Division of Social Work Studies) Claire Bailey (Division of.
Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June
Prostate Cancer Craig Blundred. Overview Disease Definition  Epidemiological Classification  Symptoms Disease Burden  Incidence  Mortality  Health.
Autism Connections Europe: UK Service Provision - UK Dr John Lawson Oxford Brookes University.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Cervical Cancer - UK December 2011 For more information.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Breast Cancer - UK December 2011 For more information.
Audit of Practice Around Record Keeping and Partner Notification Maeve Cross & Martin Murchie.
UK higher education: quality assurance at home and abroad Carolyn Campbell The Quality Assurance Agency for Higher Education.
CANCER INCIDENCE IN THE UK, 2010 AUGUST All Cancers Excluding Non-Melanoma Skin Cancer (C00-97 Excl. C44): 2010 Number of New Cases, Crude and European.
RARECARE project Cancer registries and rare cancers: quality of data, supplementary information RARECARE WP6, 3 rd meeting th National Institute of Public.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Service Provision - UK John Lawson & Nicki Holland Oxford Brookes University.
Curriculum and Assessment in Northern Ireland
What is an effective induction (within an academic context) and how do you implement it across the whole university or college? Michael Hill Action on.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
London and South East Burns Services Review Patient Stakeholder Event 15 th January 2011 The Olympic Lodge Hotel, Aylesbury.
Cancer survival in the UK and Republic of Ireland B Rachet 1, M Quinn 2, D Brewster 3, A Gavin 4, J Steward 5, H Comber 6, L Gonsalves 7, V Mak 8, MP Coleman.
A Comparative Analysis of European Media Coverage of Children and the Internet Leslie Haddon Department of Media and Communication LSE
An Outline of Automated Cancer Registration Chris Carrigan National Coordinator for Cancer Registration in England For the Automated Cancer Registration.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Colorectal Cancer - UK December 2011 For more information.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
National Cancer Intelligence Network data usage 17 November 2015 – Veronique Poirier – Principal Cancer Analyst – NCIN.
Jacques Bus Head of Unit, DG INFSO-F5 “Security” European Commission FP7 launch in the New Member States Regional on-line conference 22 January 2007 Objective.
Dr Heather O Dickinson My web page Department of Child Health University of Newcastle My web page Audit of cancer registrations notified by National Health.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
South West Public Health Observatory South West Regional Public Health Group Opportunities for future analysis by SWPHO Sean McPhail South West Public.
Trends in prostate cancer and its management in the South West Region, Hampshire and the Isle of Wight Christine Harling Julia Verne (SWPHO) Roy Maxwell.
What does the cancer landscape look like now? - The national context for cancer intelligence Jason Poole, Deputy Head (Local Interface), National Cancer.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
RARE SKIN TUMOURS IN THE SOUTH WEST J Weeks, V Poirier, J Verne, C Harling on behalf of the Skin Cancer Tumour Panel Objective NICE Improving Outcomes.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
Diabetes Health Intelligence A Summary of Information: South Central SHA.
Cheshire and Merseyside Strategic Clinical Networks Local Issues and Challenges 22 nd May 2015.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
Oesophago–Gastric Cancer
Soft Tissue Sarcoma (All Subtypes Combined): 2010
Cancer of Unknown Primary (C77-C80): 2013
Head & Neck Cancer (C00-C14, C30-C32): 2014
Digital Learning Framework Evaluation Overview
Healthy London Partnership
Kidney Cancer (C64-C66,C68): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England.
Stomach Cancer (C16): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
All Childhood Cancers:
Hodgkin Lymphoma (C81): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England.
Oesophageal Cancer (C15): 2011
Cervical Cancer (C53): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.
Prostate Cancer (C61): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.
Teenage and Young Adult Cancers by Cancer Type:
Scottish Cancer Registry and Intelligence Service (SCRIS)
Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75
Oral Cancer (C00-C06,C09-C10,C12-C14): 2011
Bowel Cancer (C18-C20): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England.
Leukaemia (C91-C95): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Uterine Cancer (C54-C55): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.
Cancer of Unknown Primary (C77-C80): 2014
CUP Incidence UK, 2012 (C77-80) CUP has the 10th highest number of new cancer cases each year in the UK   England Wales Scotland N Ireland UK Male 3,730.
The 20 Most Common Causes of Cancer Death in 2012
Epidemiology of basal and cutaneous squamous cell carcinoma in the United Kingdom : a cohort study Z C Venables123, T Nijsten4, K F Wong2, P Autier5,
Presentation transcript:

The challenges of coding cancer of unknown primary A survey of registration and reporting practices in the UK, Ireland and Australia Claudia Oehler 1, Claire Vajdic 2, Nicola Cooper 1, John Symons 3 1 National Cancer Intelligence Network, Public Health England 2 University of New South Wales, Australia 3 Cancer of Unknown Primary Foundation, UK CRUK-NCIN Partnership Programme National Cancer Intelligence Network

Content Introduction to results of the survey on registration and reporting of Cancer of Unknown Primary (CUP): 1.Overview: what is CUP? why is it problematic? 2.The survey: what was its purpose? 3.The results: what did it tell us? 4.Conclusion: what next? 2Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What is cancer of unknown primary? Cancer of unknown primary (CUP) is a diagnostic term for cancer which has spread from its initial location and where the original cancer cannot be determined with confidence. Context  9,762 cases and 10,812 deaths (UK, 2011); 16% 1-year relative survival; 57% emergencies (England, ).  ~8 th most common incident cancer (ca.15% cancers present as metastases, 1/3 no obvious origin); ~5 th most common cancer cause of death.  2010 first clinical guideline by National Institute of Clinical Excellence (NICE) recommending diagnostic pathway and multi-disciplinary teams.  2013 first Peer Review Measures (internal validation by 133 Trusts). 3Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

Why is CUP problematic? Something 'unknown' is difficult to define and treat.  Clinically heterogeneous and complex presentations; diagnosis often difficult to determine; morphology and extent of cancer crucial for outcome.  Clinical uncertainty makes registration/coding of CUP difficult.  Codes used for reporting CUP vary substantially: England: mainly four ICD10 codes C77, C78, C79 (lymphatic, respiratory/abdominal and 'other' metastases) and C80 (primary cancer site unknown) - regional variations. Others: solely C80, or additional ICD10 codes for ill-defined primary cancer sites, such as C26, C39 or C76 (ill-defined digestive, respiratory/intrathoracic, or generic sites, e.g. 'head and neck').  Obscures accurate assessment of CUP burden; nationally & internationally. Clear definition and consistent recording of CUP crucial for accurate statistics and clinically meaningful analyses. 4Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

Purpose of the survey? The aim was to compare CUP registration and reporting practices in the UK, Ireland and Australia, with a view to supporting improved national/international standardisation. Methodology:  20 registration services participated: 8 in Australia, the 8 regional NCRS in England, 1 each in Wales, Scotland, Northern Ireland and Ireland.  2-part questionnaire: Section 1 - Registration: coding guidance and system; coding scenarios; death certificate only; clarification process. Section 2 - Reporting: codes used for reporting; incidence by source of diagnosis and morphology. 5Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What did the survey tell us? Caveat: these are draft results; registration services will be given the opportunity to comment before publication.  To preserve the anonymity of individual responses, these are grouped: Registration offices in England and Australia are grouped as that; when individual answers are shown, these are numbered E1-E8 and A1-A8; these numbers were randomly assigned. Countries with a single national registry - Scotland, Wales, Northern Ireland and Ireland - are grouped here to obscure the identity of any individual registry until permission is obtained to attribute results by nation. When individual responses are shown, these countries are numbered X1-X4; these numbers were randomly assigned and do not correspond to the order in which they are listed.  Limitations: registration systems vary across countries; some of the differences may be due to a different casemix; a few questions were left blank / answers were unclear; April 2013, English registries merged to form National Cancer Registration Service. 6Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What did the survey tell us? Survey confirmed variation in registration and reporting practices on almost every aspect covered. For example, coding guidance for CUP:  Q1_Does your registry have guidelines that specifically cover the registration of CUP? 7Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What did the survey tell us? Question 4: Does a CUP cause of death get matched against a prior site-specific cancer registration? 8Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What did the survey tell us? Question 11: If additional information is sought from notifier(s), who would be contacted for it? 9Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What did the survey tell us? Question 18: Indicate the number of cases broken down by the basis of diagnosis/registration (source of information). 10Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What did the survey tell us? Question 18: Indicate the number of cases broken down by the code used to report CUP [all translated to ICD10]. 11Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

What next? Beyond the survey - two key areas: registration processes and codes/coding systems. Registration processes  Guidance for CUP: clarification of notification; source of diagnosis; follow-up  Specific rules around death certificate notifications and matching to prior diagnoses (incl. clinical)  England: impact of National Cancer Registration Service merger; but what about the wider picture (UK, Ireland, Australia; Europe and beyond)? Coding systems and codes  ICDO3 codes ≠ ICD10 C-codes; better depth of data with ICDO3 (particularly metastases)? Australian method?  Impact of CUP registration definition on mortality statistics? 12Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia

Thanks! Thanks also go to the Australian registries for their participation. 13Coding cancer of unknown primary - a registration and reporting survey in the UK, Ireland and Australia